Editas Medicine Stock Target Price and Analyst Consensus
| EDIT Stock | USD 5.35 0.11 2.01% |
The current analyst and expert consensus on Editas Medicine is Buy with 9 hold recommendations. The current projected Editas Medicine target price consensus is 13.60 with 18 analyst opinions. One of the most common ways Editas Medicine analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Editas Medicine vendors, executives, and/or customers. Editas Medicine recommendation module provides expert sentiment on the projected Editas Medicine target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on Editas Medicine to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Editas Stock please use our How to Invest in Editas Medicine guide.
Lowest Forecast 12.38 | Highest Forecast 15.1 | Target Price 13.6 |
Editas |
It's important to approach Editas Medicine's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Editas Medicine price targets
Editas Medicine's stock target price is an estimate of its future price, usually made by analysts. Using Editas Medicine's target price to determine if it is a suitable investment can be done through the following steps:- Look at Editas Medicine's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Editas Medicine's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Editas Medicine Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Editas Medicine is a key component of Editas Medicine valuation and have some predictive power on the future returns of a Editas Medicine.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Editas Medicine's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Impulse Invested over 100 shares | |
 | Dividend Beast Invested over 60 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Investor Favorites Invested over 40 shares | |
Check out Macroaxis Advice on Editas Medicine to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Editas Stock please use our How to Invest in Editas Medicine guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Editas Stock analysis
When running Editas Medicine's price analysis, check to measure Editas Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Editas Medicine is operating at the current time. Most of Editas Medicine's value examination focuses on studying past and present price action to predict the probability of Editas Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Editas Medicine's price. Additionally, you may evaluate how the addition of Editas Medicine to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
The data published in Editas Medicine's official financial statements usually reflect Editas Medicine's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Editas Medicine. For example, before you start analyzing numbers published by Editas accountants, it's critical to develop an understanding of what Editas Medicine's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Editas Medicine's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Editas Medicine's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Editas Medicine's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Editas Medicine. Please utilize our Beneish M Score to check the likelihood of Editas Medicine's management manipulating its earnings.